Aquatic Capital Management LLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1803916 CHICAGO, IL

Position in TGTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,468,178

+$2,840,809 QoQ

Shares Held

99,530

+25.8% QoQ

Ownership

0.065%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#88

of 420 holders

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Aquatic Capital Management LLC holds $144,356,048 across 88 Biotechnology names. TGTX ranks #6 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	32,577	$20,313,062
2	CYTK	Cytokinetics Inc	125,090	$10,656,417
3	TVTX	Travere Therapeutics, Inc.	157,710	$8,959,505
4	ARGX	Argenx SE	7,697	$7,141,045
5	PTCT	Ptc Therapeutics, Inc.	83,470	$6,808,647
6	TGTX	Tg Therapeutics, Inc. This page	99,530	$5,468,178
7	ALNY	Alnylam Pharmaceuticals, Inc.	15,480	$4,659,944
8	MIRM	Mirum Pharmaceuticals, Inc.	36,670	$4,292,956

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,468,178	99,530	+25.8%	Shares	Sole	2026-08-14
2026-03-31	$2,627,369	79,090	+82.9%	Shares	Sole	2026-05-15
2025-12-31	$1,288,984	43,240	-42.7%	Shares	Sole	2026-02-17
2025-09-30	$2,727,004	75,488	+45.4%	Shares	Sole	2025-11-14
2024-09-30	$1,213,941	51,900	-73.0%	Shares	Sole	2024-11-14
2024-03-31	$2,918,799	191,900	+1598.2%	Shares	Sole	2024-05-15
2023-12-31	$193,004	11,300	-23.6%	Shares	Sole	2024-02-14
2023-09-30	$123,728	14,800	-28.8%	Shares	Sole	2023-11-14
2023-03-31	$312,832	20,800	+593.3%	Shares	Sole	2023-05-15
2022-09-30	$17,760	3,000	-11.8%	Shares	Sole	2022-11-14
2022-06-30	$14,450	3,400	+78.9%	Shares	Sole	2022-08-15
2022-03-31	$18,069	1,900	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.